$SRE — AVOID 📊 | 6 MONTHS THESIS

$SRE — AVOID 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $3.7B | EPS $1.28 vs $1.17 🟢 💡 Consensus may be extrapolating the recent beat into sustained above-trend growth, ignoring the likelihood of mean reversion in the utility sector’s P/E multiple. The market appears to be pricing in a bull case without adequately discounting regulatory or macro headwinds. 📉 Reward/risk: 0.3:1 🏢 Business Quality: 5/10 📊 Valuation: rich — trailing P/E 31.4x at 108th historical percentile; forward P/E ~18.4x based on guidance midpoint is near peer median but fails to compensate... 🔮 Catalyst: None identified; the recent earnings beat is already priced in, and no near-term regulatory, rate, or company-specific catalyst is expected within 3 months. 💰 Entry: $92.73, stop $66.47, target $100.25 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/SRE0625

🎯 Q1 2026 | Rev $3.7B | EPS $1.28 vs $1.17 🟢